seborrheic%20dermatitis
SEBORRHEIC DERMATITIS
Seborrheic dermatitis is a chronic inflammatory skin disorder characterized by fine scaling and erythema mostly confined to areas where sebaceous glands are prominent.
Pityrosporum ovale infection is common in seborrheic dermatitis.
The characteristic pattern is based on age group.
In infants it appears as cradle cap. It is a diffuse or focal scaling and crusting on the vertex of the scalp that sometimes accompanied by inflammation.
In young children, there is Tinea amiantacea which is one or several patches of dense, plate-like scales, 2-10 cm in size that appear anywhere on the scalp.
While adolescents have dandruff which are fine, dry, white, non-inflammatory scalp scaling with minor itching.
  1. Cohen S. Should we treat infantile seborrheic dermatitis with topical antifungals or topical steroids?. Arch Dis Childhood. 2004 Mar;89(3):288-289. PMID: 14977719
  2. Arora V, Arora S. Management of infantile seborrheic dermatitis. Am Fam Physician. 2007 Mar;75:807. PMID: 17390592
  3. Gupta AK, Skinner AR. Ciclopirox for the treatment of superficial fungal infections: a review. Int J Dermatol. 2003 Sep;42(Suppl 1):3-9. PMID: 12895181
  4. Gupta AK, Bluhm R, Cooper EA, et al. Seborrheic dermatitis. Dermatol Clin. 2003 Jul;21:401-412. PMID: 12956195
  5. Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician. 2000 May;61(9):2703-2714. PMID: 10821151
  6. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006 Jul;74(1):125-130. PMID: 16848386
  7. Vena GA, Micali G, Santoianni P, et al. Oral terbinafine in the treatment of multi-site seborrheic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol. 2005;18(4):745-753. PMID: 16388724
  8. Morelli JG. Eczematous disorders. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of Pediatrics. 18th ed. Philadelphia: Saunders, Elsevier; 2007
  9. Seite S, Rougier A. Lipohydroxy acid containing shampoo in the treatment of scalp seborrheic dermatitis. In: Preedy VR. Handbook of hair in health and disease: Wageningen Academic Publishers; 2012:446-476
  10. Robertson DB, Maibach HI. Dermatologic pharmacology. In: Katzung BG. Basic and clinical pharmacology. 8th ed. New York: Lange Medical Books/McGraw-Hill; 2001
  11. Habif TP. Psoriasis and other papulosquamous diseases. Clinical dermatology: A color guide to diagnosis and therapy. 4th ed. Pennsylvania: Mosby, Elsevier; 2004
  12. Shaw JC, Parker F. Psoriasis and other papulosquamous diseases. In: Noble J, Greene HL, Levinson W, et al. Textbook of primary care medicine. 3rd ed. Philadelphia: Mosby, Inc; 2001
  13. MedWormhttp://www.medworm.com/rss/index.php/Allergy-%26-Immunology/3/http://www.medworm.com/rss/medicalfeeds/specialities/Allergy-Immunology.xml
  14. MedWorm http://www.medworm.com/rss/index.php/Dermatology/12/ http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology-News.xml
  15. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  16. Finnish Medical Society Duodecim. Seborrheic dermatitis. National Guideline Clearinghouse. http://www.guidelines.gov/summary/summary.aspx?doc_id=11044&nbr=005823&string=. 2007
  17. Finnish Medical Society Duodecim. Seborrheic dermatitis. National Guideline Clearinghouse. http://www. guidelines.gov/. 2007
  18. Goldenberg G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol. 2013 Feb;6(2):44-49. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579488/pdf/jcad_6_2_44.pdf. Accessed 26 Sep 2013. PMID: 23441240
  19. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. The Journal of Clinical and Aesthetic Dermatology. 2011 May;4(5):32-38. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100109/pdf/jcad_4_5_32.pdf. PMID: 21607192
  20. Cheong WK, Yeung CK, Torsekar RG, et al. Treatment of seborrheic dermatitis in Asia: a consensus guide. Skin Appendage Disord. 2015 Nov;1:187-196. doi: 10.1159/000444682.
  21. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015 Feb;91(3):185-190. http://www.aafp.org/afp/2015/0201/p185.pdf. PMID: 25822272
  22. Marcdante KJ, Kliegman RM. Seborrheic dermatitis. In: Marcdante KJ, Kliegman RM. Nelson Essentials of Pediatrics. 7th ed. Philadelphia, PA: Saunders, Elsevier Inc; 2015.
  23. Guiseppe M, Lacarrubba F, Dall'Oglio F, Tedeschi A, Dirschka T. A new proposed severity score for seborrheic dermatitis of the face: SEborrheic Dermatitis Area and Severity Index (SEDASI). J Am Acad Dermatol. 2017 Jun;76(6)(Suppl 1):AB18. doi: 10.1016/j.jaad.2017.04.088.
  24. Patterson JW. The spongiotic reaction pattern. In: Patterson JW. Weedon's Skin Pathology. 4th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2016.
  25. Sasseville D. Seborrheic dermatitis in adolescents and adults. UptoDate. https://www.uptodate.com/. Mar 2018.
  26. Sasseville D. Cradle cap and seborrheic dermatitis in infants. UpToDate. https://www.uptodate.com/. Aug 2019.
  27. Sasseville D. Seborrheic dermatitis in adolescents and adults. UpToDate. https://www.uptodate.com/. Nov 2018.
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.

Tristan Manalac, 5 days ago
Users of electronic nicotine delivery systems are likely to have received a diagnosis of clinical depression in the past, according to a recent study.
Pearl Toh, 06 Dec 2019
Getting just under one extra hour of sleep per night can go a long way for the health of college students, who are often sleep-deprived, a study suggests.
Jairia Dela Cruz, 3 days ago
Use of isatuximab (Isa) in combination with pomalidomide and dexamethasone (PomDex) appears to lead to more favourable outcomes in elderly patients with relapsed/refractory multiple myeloma (RRMM) as compared with PomDex alone, according to the results of a subgroup analysis of the ICARIA-MM trial presented at the 61st Annual Meeting of the American Society of Hematology (ASH 2019).